We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Diarrheal Etiology and Impact of Coinfections on Rotavirus Vaccine Efficacy Estimates in a Clinical Trial of a Monovalent Human–Bovine (116E) Oral Rotavirus Vaccine, Rotavac, India.
- Authors
Praharaj, Ira; Platts-Mills, James A; Taneja, Sunita; Antony, Kalpana; Yuhas, Krista; Flores, Jorge; Cho, Iksung; Bhandari, Nita; Revathy, R; Bavdekar, Ashish; Rongsen-Chandola, Temsunaro; McMurry, Timothy; Houpt, Eric R; Kang, Gagandeep
- Abstract
Background Rotavirus vaccine efficacy (VE) estimates in low-resource settings are lower than in developed countries. We detected coinfections in cases of severe rotavirus diarrhea in a rotavirus VE trial to determine whether these negatively impacted rotavirus VE estimates. Methods We performed TaqMan Array Card assays for enteropathogens on stools from rotavirus enzyme immunoassay–positive diarrhea episodes and all severe episodes (Vesikari score ≥11), from a phase 3 VE trial of Rotavac, a monovalent human–bovine (116E) rotavirus vaccine, carried out across 3 sites in India. We estimated pathogen-specific etiologies of diarrhea, described associated clinical characteristics, and estimated the impact of coinfections on rotavirus VE using a test-negative design. Results A total of 1507 specimens from 1169 infants were tested for the presence of coinfections. Rotavirus was the leading cause of severe diarrhea even among vaccinated children, followed by adenovirus 40/41, Shigella /enteroinvasive Escherichia coli , norovirus GII, sapovirus, and Cryptosporidium species. Bacterial coinfections in rotavirus-positive diarrhea were associated with a longer duration of diarrhea and protozoal coinfections with increased odds of hospitalization. Using the test-negative design, rotavirus VE against severe rotavirus gastroenteritis increased from 49.3% to 60.6% in the absence of coinfections (difference, 11.3%; 95% confidence interval, –10.3% to 30.2%). Conclusions While rotavirus was the dominant etiology of severe diarrhea even in vaccinated children, a broad range of other etiologies was identified. Accounting for coinfections led to an 11.3% increase in the VE estimate. Although not statistically significant, an 11.3% decrease in VE due to presence of coinfections would explain an important fraction of the low rotavirus VE in this setting.
- Subjects
FECAL analysis; BIOLOGICAL assay; CONFIDENCE intervals; CRYPTOSPORIDIOSIS; DIARRHEA; ESCHERICHIA coli diseases; GASTROENTERITIS; HOSPITAL care; IMMUNOENZYME technique; ORAL drug administration; RETROVIRUS diseases; SHIGELLOSIS; VIRUSES; STATISTICAL significance; TREATMENT effectiveness; SEVERITY of illness index; DISEASE duration; ROTAVIRUS vaccines; NOROVIRUS diseases; RNA virus infections; ODDS ratio; MIXED infections; DISEASE complications
- Publication
Clinical Infectious Diseases, 2019, Vol 69, Issue 2, p243
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/ciy896